Effects of lentiviral vector‑mediated shRNA silencing of TGFβ1 on the expression of Col1a1 in rat hepatic stellate cells
- Authors:
- Gan‑Ping Bai
- Guo‑He Yan
- Guo‑Jian Wang
- Ping Wan
- Xiao‑Fei Liu
- Heng Wang
- Rong‑Hua Zhang
View Affiliations
Affiliations: Department of Integrated Chinese and Western Medicine, Southwest Hospital, The Third Military Medical University, Chongqing 400038, P.R. China, Institute of Combined Injuries, The State Key Laboratory of Trauma, Burns and Combined Injury, College of Preventive Medicine, The Third Military Medical University, Chongqing 400038, P.R. China
- Published online on: July 6, 2017 https://doi.org/10.3892/mmr.2017.6945
-
Pages:
2785-2790
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The present study aimed to construct a lentiviral RNA interference (RNAi) vector targeting the transforming growth factor β1 (TGFβ1) gene of rats, in order to examine its effect on silencing of the TGFβ1 gene and on the expression of collagen type 1 α1 (Col1a1) in HSC‑T6 rat hepatic stellate cells. Three RNAi sites of the TGFβ1 gene were selected according to its CDs sequence. Three pairs of small interfering RNA (siRNA) of these RNAi sites were synthesized and then transfected into HSC‑T6 cells, respectively, to confirm the optimal siRNA sequence via reverse transcription‑polymerase chain reaction analysis. Subsequently, shRNA targeting the sequence of the optimal siRNA was designed, synthesized and annealed to form a double‑stranded structure. The annealed oligonucleotide fragment was cloned into pGreenPuro plasmids to establish the pGreenPuro/TGFβ1 shRNA lentiviral vector, which was then transfected into 293T cells, following identification by restriction enzyme digestion and sequencing for the production of lentiviral particles exhibiting high reactivity. These particles were used to infect HSC‑T6 cells, following which the expression of GFP in the transfected cells was observed under an inverted microscope. The effects on TGFβ1 gene silencing and the expression levels of Colla1 were detected at the mRNA and protein levels. The results provided confirmation of the optimal siRNA sequence. Enzyme digestion and sequencing verified successful construction of the pGreenPuro/TGFβ1 shRNA lentiviral vector. This lentiviral vector effectively silenced the TGFβ1 gene in the HSC‑T6 cells, and inhibited the expression of Col1a1 at the mRNA and protein levels. Taken together, the lentiviral RNAi vector targeting the TGFβ1 gene of rats was successfully constructed, which effectively silenced the TGFβ1 gene of the HSC‑T6 cells and inhibited the expression of Col1a1.
View Figures |
Figure 1
|
 |
Figure 2
|
 |
Figure 3
|
 |
Figure 4
|
 |
Figure 5
|
 |
Figure 6
|
View References
|
1
|
Mann DA and Marra F: Fibrogenic signalling
in hepatic stellate cells. J Hepatol. 52:949–950. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu L, Zheng N, He Q, Li R, Zhang K and
Liang T: Puerarin, isolated from Pueraria lobata (Willd.),
protects against hepatotoxicity via specific inhibition of the
TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic
effect. Phytomedicine. 20:1172–1179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Atzori L, Poli G and Perra A: Hepatic
stellate cell: A star cell in the live. Int J Biochem Cell Biol.
41:1639–1642. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vogel S, Piantedosi R, Frank J, Lalazar A,
Rockey DC, Friedman SL and Blaner WS: An immortalized rat liver
stellate cell line (HSC-T6): A new cell model for the study of
retinoid metabolism in vitro. J Lipid Res. 41:882–893.
2000.PubMed/NCBI
|
|
5
|
Baghy K, Iozzo RV and Kovalszky I:
Decorin-TGFβ axis in hepatic fibrosis and cirrhosis. J Histochem
Cytochem. 60:262–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Inagaki Y, Higashiyama R and Higashi K:
Novel anti-fibrotic modalities for liver fibrosis: Molecular
targeting and regenerative medicine in fibrosis therapy. J
Gastroenterol Hepatol. 27:(Suppl 2). S85–S88. 2012. View Article : Google Scholar
|
|
7
|
Gressner OA, Rizk MS, Kovalenko E,
Weiskirchen R and Gressner AM: Changing the pathogenetic roadmap of
liver fibrosis? Where did it start; where will it go? J
Gastroenterol Hepatol. 23:1024–1035. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kajdaniuk D, Marek B, Borgiel-Marek H and
Kos-Kudła B: Transforming growth factor β1 (TGFbeta1) in physiology
and pathology. Endokrynol Pol. 64:384–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ieronimakis N, Hays AL, Janebodin K,
Mahoney WM Jr, Duffield JS, Majesky MW and Reyes M: Coronary
adventitial cells are linked to perivascular cardiac fibrosis via
TGFβ1 signaling in the mdx mouse model of Duchenne muscular
dystrophy. J Mol Cell Cardiol. 63:122–134. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ashihara E, Kawata E and Maekawa T: Future
prospect of RNA interference for cancer therapies. Curr Drug
Targets. 11:345–360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen J and Xie J: Progress on RNAi-based
molecular medicines. Int J Nanomedicine. 7:3971–3980. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zeng Z, Zhang C and Chen J:
Lentivirus-mediated RNA interference of DC-STAMP expression
inhibits the fusion and resorptive activity of human osteoclasts. J
Bone Miner Metab. 31:409–416. 2013. View Article : Google Scholar : PubMed/NCBI
|
